INCYTE CORPORATION Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amortization, Amount
INCYTE CORPORATION (INCY) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amortization, Amount of $1.09 million for the 12-month period ending 2015-12-31, per its 10-K filed 2018-02-15.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpenseAmortization · last filed 2018-02-15
- INCYTE CORPORATION effective income tax rate reconciliation, nondeductible expense, amortization, amount for fiscal 2015 was $1.09M, a 52.62% decline from fiscal 2014.
- INCYTE CORPORATION effective income tax rate reconciliation, nondeductible expense, amortization, amount for fiscal 2014 was $2.29M, a 65.48% decline from fiscal 2013.
- INCYTE CORPORATION effective income tax rate reconciliation, nondeductible expense, amortization, amount for fiscal 2013 was $6.64M, a 20.39% decline from fiscal 2012.
- INCYTE CORPORATION effective income tax rate reconciliation, nondeductible expense, amortization, amount for fiscal 2012 was $8.35M, a 9.66% increase from fiscal 2011.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amortization, Amount 12 month |
|---|---|
| 2015-12-31 | $1.09M 10-K · filed 2018-02-15 |
| 2014-12-31 | $2.29M 10-K · filed 2017-02-14 |
| 2013-12-31 | $6.64M 10-K · filed 2016-02-12 |
| 2012-12-31 | $8.35M 10-K · filed 2015-02-17 |
| 2011-12-31 | $7.61M 10-K · filed 2014-02-21 |
| 2010-12-31 | $6.94M 10-K · filed 2013-02-21 |
| 2009-12-31 | $1.66M 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |